Multidrug-resistant urinary tract isolates of Escherichia coli from Ribeirão Preto, São Paulo, Brazil

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorSanto, Edilene
dc.creatorSalvador, Miriam Mendonça
dc.creatorMarin, José Moacir
dc.date2014-05-27T11:22:41Z
dc.date2016-10-25T18:24:44Z
dc.date2014-05-27T11:22:41Z
dc.date2016-10-25T18:24:44Z
dc.date2007-12-01
dc.date.accessioned2017-04-06T01:28:08Z
dc.date.available2017-04-06T01:28:08Z
dc.identifierBrazilian Journal of Infectious Diseases, v. 11, n. 6, p. 575-578, 2007.
dc.identifier1413-8670
dc.identifierhttp://hdl.handle.net/11449/70075
dc.identifierhttp://acervodigital.unesp.br/handle/11449/70075
dc.identifier10.1590/S1413-86702007000600010
dc.identifierS1413-86702007000600010
dc.identifierWOS:000254388800010
dc.identifierS1413-86702007000600010.pdf
dc.identifier2-s2.0-41149138037
dc.identifierhttp://dx.doi.org/10.1590/S1413-86702007000600010
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/891226
dc.descriptionMultiple resistances to antimicrobial drugs arising in Escherichia coli isolates may complicate therapeutic management of urinary tract infection (UTI) by this organism. In order to assess the multidrug resistance (MDR) among urinary E. coli isolates, we have tested 11 antimicrobial drugs against 67 isolates from outpatients attended in a tertiary-care teaching hospital and of 78 isolates from a municipal health unit, respectively in Ribeirão Preto, State of São Paulo, Brazil. Seventy-six percent and 22% of the isolates from the tertiary-care hospital and the municipal unit, respectively, were resistant to three or more different classes of agents, and were considered to present MDR. Among the isolates from the hospital patients, 73.0%, 65.0%, 58.0%, 58.0% and 31.0% were resistant to tetracycline, ampicillin, cephalothin, trimethoprim-sulfamethoxazole (TMP/SMX) and norfloxacin, respectively; resistance from the municipal unit patients were 31.0%, 37.0%, 8.0%, 29.0% and 12.0% respectively, to the same drugs. The predominant phenotype among the MDR isolates presented is ampicillin, TMP/SMX and tetracycline resistance. The high prevalence of drug resistance among UTI patients calls for continuous surveillance to assure effective control of this infection. © 2007 by The Brazilian Journal of Infectious Diseases and Contexto Publishing. All rights reserved.
dc.languageeng
dc.relationBrazilian Journal of Infectious Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAntimicrobial susceptibility
dc.subjectEscherichia coli
dc.subjectMultidrug-resistance
dc.subjectUrinary tract infections
dc.subjectampicillin
dc.subjectcefalotin
dc.subjectcefoxitin
dc.subjectceftriaxone
dc.subjectcefuroxime
dc.subjectcotrimoxazole
dc.subjectgentamicin
dc.subjectnitrofurantoin
dc.subjectnorfloxacin
dc.subjecttetracycline
dc.subjecttobramycin
dc.subjectadolescent
dc.subjectadult
dc.subjectantibiotic resistance
dc.subjectantibiotic sensitivity
dc.subjectbacterium isolate
dc.subjectBrazil
dc.subjectchild
dc.subjectclinical article
dc.subjectconcentration response
dc.subjectfemale
dc.subjecthuman
dc.subjectinfant
dc.subjectinfection control
dc.subjectmale
dc.subjectmultidrug resistance
dc.subjectoutpatient
dc.subjectphenotype
dc.subjecttertiary health care
dc.subjecturinary tract infection
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAnti-Bacterial Agents
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectDrug Resistance, Multiple
dc.subjectEscherichia coli Infections
dc.subjectFemale
dc.subjectHumans
dc.subjectInfant
dc.subjectInfant, Newborn
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPhenotype
dc.subjectUrinary Tract Infections
dc.titleMultidrug-resistant urinary tract isolates of Escherichia coli from Ribeirão Preto, São Paulo, Brazil
dc.typeOtro


Este ítem pertenece a la siguiente institución